AAAAI VJC logo

AAAAI-NAIA/JACI: In Practice Virtual Journal Club: January 29, 2020

January 29, 2020

Please Note: Times listed are Central Standard Time

The Virtual Journal Club is a one hour live webinar open to all AAAAI members that will focus on the newest clinically relevant content published in JACI: In Practice. The presenters will review research relevant to your allergy/immunology practice in an interactive format.

The January 29, 2020 webinar will focus on two journal articles as follows (click the Program tab to download the PDFs):

Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses, Goldberg M, et al.

Discussion Leader: Jaclyn Bjelac, MD

Mentor: Brian Vickery, MD FAAAAI

Timing of Introduction, Sensitization and Allergy to Highly-Allergenic Foods at Age 3 Years in a General-Population Canadian Cohort, Simons E, et al.

Discussion Leader: Neema Izadi, MD MS

Mentor: David Fleischer, MD FAAAAI


 

Target Audience

  • Allergist/Immunologists
  • Fellows-in-Training

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Determine risk factors and treatment outcomes for oral immunotherapy-induced gastrointestinal symptoms and
    eosinophilic responses
  • Recognize associations between age of dietary introduction of peanut, egg, and cow's milk in general-population
    infants and sensitization/clinical IgE-mediated allergy to the specific highly-allergenic food being introduced
Summary
Available credit: 
  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.
Course opens: 
01/10/2020
Course expires: 
12/31/2020
Event starts: 
01/29/2020 - 7:30pm
Event ends: 
01/29/2020 - 8:35pm
Cost:
$0.00
Rating: 
0
Goldberg M, et al. Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses. J Allergy Clin Immunol Pract 2020; In Press.

Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced GI Symptoms and Eosinophilic Responses (OITIGER).pdf


Simons E, et al. Timing of Introduction, Sensitization and Allergy to Highly-Allergenic Foods at Age 3 Years in a General-Population Canadian Cohort. J Allergy Clin Immunol Pract 2019.

Timing of Introduction, Sensitization and Allergy to Highly-Allergenic Foods at Age 3 Years in a General-Population Canadian Cohort.pdf

 

 

Planning Committee

Benjamin Prince, MD MCSI FAAAAI
Nationwide Children's Hospital, Columbus, OH
Relevant relationships: None

Ashwini Reddy, MD
Children's Hospital of Philadephia/University of Pennsylvania, Philadelphia, PA
Relevant relationships: None

Michael Schatz, MD MS FAAAAI
Kaiser Permanente Medical Center, San Diego, CA
Relevant relationships: None

Maria Slack, MD
Blanchard Valley Hospital, Findlay, OH
Relevant relationships: None

Jonathan Tam, MD
Children's Hospital Los Angeles, Los Angeles, CA
Relevant relationships: None


Faculty

Jaclyn Bjelac, MD
Cleveland Clinic, Cleveland, OH
Relevant relationships: None

David Fleischer, MD FAAAAI
Children's Hospital Colorado, Aurora, CO
Relevant relationships: DBV Technologies, FARE, FAACT, National Peanut Board (advisory board/council)

Neema Izadi, MD MS
Children's Hospital Los Angeles, Los Angeles, CA
Relevant relationships: None

Christina Kwong, MD
Washington University in St. Louis, St. Louis, MO
Relevant relationships: None

Brian Vickery, MD FAAAAI
Emory University, Atlanta, GA
Relevant relationships: Aimmune Therapeutics (advisory board)


Content Reviewer

Kara Wada, MD
Nationwide Children’s Hospital, Columbus, OH
Relevant relationships: None


AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on December 31, 2020. Requests to claim credit on or after January 1, 2020 will be subject to an administrative fee.

AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org

Questions

Activity-related questions should be directed to Rebecca Brandt at rbrandt@aaaai.org.

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.

Accreditation Period

Course opens: 
01/10/2020
Course expires: 
12/31/2020

Price

Cost:
$0.00
Please login or register to take this course.

 

 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.